Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. APLS

APLS logo
APLS
0 USD
%

Access earnings results, analyst expectations, report, slides, earnings call, and transcript.

No Data

No Data

APLS Transcript

K92 Mining Inc. (KNT:CA) Q4 2025 Earnings Call Transcript
Positive3-2

The earnings call highlights significant production growth, record revenue, and strong cash flow, indicating robust financial performance. Despite elevated costs due to expansion, the company achieved cost efficiencies and maintained a strong cash position. The Q&A session revealed positive operational progress and no major concerns from analysts. Given these factors, along with optimistic guidance and strong financial metrics, the stock price is likely to experience a positive movement in the next two weeks.

Apellis Pharmaceuticals, Inc. (APLS) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Neutral3-2
Apellis Pharmaceuticals, Inc. (APLS) Q4 2025 Earnings Call Transcript
Positive2-24

The earnings call summary highlights strategic growth initiatives for SYFOVRE and EMPAVELI, with plans for market expansion and product development. While financial guidance is stable, new tools and education initiatives indicate a positive outlook. The Q&A session reveals optimism about market leadership and innovation, though some uncertainty exists around specific metrics. Overall, the strategic focus on growth and market expansion, coupled with a commitment to supporting patient access, suggests a positive sentiment, likely leading to a stock price increase in the short term.

Apellis Pharmaceuticals, Inc. (APLS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Neutral1-12

APLS Slides

PDFApellis Q3 2025 slides: Revenue surges on licensing deals despite SYFOVRE slowdown
2025-10-30
PDFApellis Q2 2025 slides: EMPAVELI approval offsets revenue decline
2025-07-31
PDFApellis Q1 2025 slides: SYFOVRE maintains market lead despite revenue decline
2025-05-07

APLS Report

Apellis Pharmaceuticals, Inc. 10-Q
10-Q
2024-11-05
Apellis Pharmaceuticals, Inc. 10-Q
10-Q
2024-05-07
Apellis Pharmaceuticals, Inc. 10-K
10-K
2024-02-27
Apellis Pharmaceuticals, Inc. 10-Q
10-Q
2023-11-01

Frequently Asked Questions

Where does this earnings call transcript come from?

All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.

How soon is the transcript available after the earnings call ends?

Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.

Is the transcript edited or altered in any way?

No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.

Why do some answers appear as “Unclear” or “Inaudible”?

When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.

Who creates the AI Summary and Key Q&A highlights shown above the transcript?

They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.

Explore More Earnings

PENG logo
PENG
2026-07-07 16:05:00
after hour
After Hours
Revenue
$478.71M
+10.05%
EPS
-$0.71
+12.70%
AI Prediction
-
KRUS logo
KRUS
2026-07-07 16:06:00
after hour
After Hours
Revenue
$85.92M
-0.40%
EPS
-$0.03
+160.00%
AI Prediction
-
SAR logo
SAR
2026-07-07 16:24:00
after hour
After Hours
Revenue
$30.78M
-2.82%
EPS
-$0.47
-12.96%
AI Prediction
-
EPAC logo
EPAC
2026-07-07 17:04:00
after hour
After Hours
Revenue
$167.55M
+1.86%
EPS
-$0.60
+22.45%
AI Prediction
-
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia